Doctors are “overtesting” men for prostate cancer and not targeting “those most likely to benefit,” researchers have warned.
Prostate cancer is the most commonly diagnosed cancer in the UK, affecting 55,300 men a year, but prostate-specific antigen testing (PSA) is only routinely recommended for men with certain symptoms.
